The guiding mission of the Centre for Inflammation Biology and Cancer Immunology (CIBCI) is to be an internationally prominent centre of excellence focused on enhancing our fundamental and applied knowledge of inflammation biology, tumour immunobiology, and their bearing upon each other.
CIBCI aspires to provide new insights into the understanding, diagnosis and treatment of inflammation, its associated pathologies, and its contribution to tumour immunobiology. Our collective aim is to identify key mechanisms and pathways underlying inflammation and cancer and to open new opportunities to innovate the treatment of human disease.
Staff and students of CIBCI, with invited guests, at the official opening of CIBCI in Oct 2018.
Located on the first floor of New Hunt's House, Guy’s Campus, the interdisciplinary programme of CIBCI brings together researchers working on cellular, molecular and clinically relevant mechanisms of inflammation and tumour immunobiology. Our researchers develop, investigate and apply cutting-edge models and techniques, both experimental and computational, to advance the understanding of human inflammatory disease and cancer.
CIBCI is part of the School of Immunology and Microbial Sciences and affiliated with the King’s Health Partners CRUK Cancer Centre. We foster a collaborative environment that stimulates interactions between all who work in inflammation biology and/or cancer immunology across the King’s faculty, with the aim to advance both research and education in these areas.
The Centre accommodates a large open plan wet laboratory, adjacent cell culture rooms, flow-cytometry facilities, fly and rodent holding suites, an imaging suite, and bioinformatics suite. The Centre also features a large open plan office space adjacent to dedicated PI offices. CIBCI is supported by Versus Arthritis, the Guy’s & St Thomas’ Charity and Cancer Research UK.